161 related articles for article (PubMed ID: 8649265)
1. Randomised trial of SPf66 vaccine against Plasmodium falciparum malaria in children in southern Tanzania.
Alonzo PL; Smith T; Schellenberg JR; Masanja H; Mwankusye S; Urassa H; Bastos De Azevedo I; Chongela J; Kobero S; Menendez C
Med Trop (Mars); 1995; 55(4 Suppl):41-6. PubMed ID: 8649265
[TBL] [Abstract][Full Text] [Related]
2. Efficacy trial of malaria vaccine SPf66 in Gambian infants.
D'Alessandro U; Leach A; Drakeley CJ; Bennett S; Olaleye BO; Fegan GW; Jawara M; Langerock P; George MO; Targett GA
Lancet; 1995 Aug; 346(8973):462-7. PubMed ID: 7637479
[TBL] [Abstract][Full Text] [Related]
3. Randomised trial of efficacy of SPf66 vaccine against Plasmodium falciparum malaria in children in southern Tanzania.
Alonso PL; Smith T; Schellenberg JR; Masanja H; Mwankusye S; Urassa H; Bastos de Azevedo I; Chongela J; Kobero S; Menendez C
Lancet; 1994 Oct; 344(8931):1175-81. PubMed ID: 7934537
[TBL] [Abstract][Full Text] [Related]
4. The development of malaria vaccines: SPf66--what next?
Tanner M; Alonso PL
Schweiz Med Wochenschr; 1996 Jul; 126(27-28):1210-5. PubMed ID: 8766632
[TBL] [Abstract][Full Text] [Related]
5. Epidemiological features of severe paediatric malaria in north western Ethiopia.
Seboxa T; Snow RW
East Afr Med J; 1997 Dec; 74(12):780-3. PubMed ID: 9557422
[TBL] [Abstract][Full Text] [Related]
6. Malaria morbidity and immunity among residents of villages with different Plasmodium falciparum transmission intensity in North-Eastern Tanzania.
Lusingu JP; Vestergaard LS; Mmbando BP; Drakeley CJ; Jones C; Akida J; Savaeli ZX; Kitua AY; Lemnge MM; Theander TG
Malar J; 2004 Jul; 3():26. PubMed ID: 15282030
[TBL] [Abstract][Full Text] [Related]
7. Synthetic vaccine update: applying lessons learned from recent SPf66 malarial vaccine physicochemical, structural and immunological characterization.
Bermúdez A; Reyes C; Guzmán F; Vanegas M; Rosas J; Amador R; Rodríguez R; Patarroyo MA; Patarroyo ME
Vaccine; 2007 May; 25(22):4487-501. PubMed ID: 17403557
[TBL] [Abstract][Full Text] [Related]
8. An evaluation of surveillance of malaria at primary health care level in Kenya.
Some ES; Koech DK; Ochogo JO; Ocholla F; Mumbi F
East Afr Med J; 1997 Sep; 74(9):573-5. PubMed ID: 9487433
[TBL] [Abstract][Full Text] [Related]
9. Randomised double-blind placebo-controlled trial of SPf66 malaria vaccine in children in northwestern Thailand. Shoklo SPf66 Malaria Vaccine Trial Group.
Nosten F; Luxemburger C; Kyle DE; Ballou WR; Wittes J; Wah E; Chongsuphajaisiddhi T; Gordon DM; White NJ; Sadoff JC; Heppner DG
Lancet; 1996 Sep; 348(9029):701-7. PubMed ID: 8806288
[TBL] [Abstract][Full Text] [Related]
10. Prevalence of malaria parasitaemia and associated factors in febrile under-5 children seen in Primary Health Care Centres in Jos, North Central Nigeria.
Ikeh EI; Teclaire NN
Niger Postgrad Med J; 2008 Jun; 15(2):65-9. PubMed ID: 18575475
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of SPf66 vaccine against Plasmodium falciparum malaria in children.
Trape JF; Rogier C
Lancet; 1995 Jan; 345(8942):134-5. PubMed ID: 7815878
[No Abstract] [Full Text] [Related]
12. Humoral immune responses during a malaria vaccine trial in Tanzanian infants.
Galindo CM; Acosta CJ; Schellenberg D; Aponte JJ; Roca A; Oettli A; Urassa H; Armstrong Schellenberg J; Kahigwa E; Ascaso C; Mshinda H; Lwilla F; Vidal J; Menendez C; Tanner M; Alonso PL
Parasite Immunol; 2000 Sep; 22(9):437-43. PubMed ID: 10972850
[TBL] [Abstract][Full Text] [Related]
13. Cytophilic antibodies to Plasmodium falciparum glutamate rich protein are associated with malaria protection in an area of holoendemic transmission.
Lusingu JP; Vestergaard LS; Alifrangis M; Mmbando BP; Theisen M; Kitua AY; Lemnge MM; Theander TG
Malar J; 2005 Sep; 4():48. PubMed ID: 16194274
[TBL] [Abstract][Full Text] [Related]
14. Duration of protection and age-dependence of the effects of the SPf66 malaria vaccine in African children exposed to intense transmission of Plasmodium falciparum.
Alonso PL; Smith TA; Armstrong-Schellenberg JR; Kitua AY; Masanja H; Hayes R; Hurt N; Font F; Menendez C; Kilama WL; Tanner M
J Infect Dis; 1996 Aug; 174(2):367-72. PubMed ID: 8699068
[TBL] [Abstract][Full Text] [Related]
15. [The investigational vaccine SPf66 against Plasmodium falciparum: myth or reality?].
Robert F; Gazin P
Sante; 1996; 6(1):56-7. PubMed ID: 8612015
[No Abstract] [Full Text] [Related]
16. Do antibody responses to malaria vaccine candidates influenced by the level of malaria transmission protect from malaria?
Nebie I; Tiono AB; Diallo DA; Samandoulougou S; Diarra A; Konate AT; Cuzin-Ouattara N; Theisen M; Corradin G; Cousens S; Ouattara AS; Ilboudo-Sanogo E; Sirima BS
Trop Med Int Health; 2008 Feb; 13(2):229-37. PubMed ID: 18304269
[TBL] [Abstract][Full Text] [Related]
17. Reduction in the mean number of Plasmodium falciparum genotypes in Gambian children immunized with the malaria vaccine SPf66.
Haywood M; Conway DJ; Weiss H; Metzger W; D'Alessandro U; Snounou G; Targett G; Greenwood B
Trans R Soc Trop Med Hyg; 1999 Feb; 93 Suppl 1():65-8. PubMed ID: 10450429
[TBL] [Abstract][Full Text] [Related]
18. Clinical and parasitological studies on immunity to Plasmodium falciparum malaria in children.
Høgh B
Scand J Infect Dis Suppl; 1996; 102():1-53. PubMed ID: 9060051
[TBL] [Abstract][Full Text] [Related]
19. Relationship between the intensity of exposure to malaria parasites and infection in the Usambara Mountains, Tanzania.
Bødker R; Msangeni HA; Kisinza W; Lindsay SW
Am J Trop Med Hyg; 2006 May; 74(5):716-23. PubMed ID: 16687668
[TBL] [Abstract][Full Text] [Related]
20. Is molecular biology the best alternative for diagnosis of malaria to microscopy? A comparison between microscopy, antigen detection and molecular tests in rural Kenya and urban Tanzania.
Mens P; Spieker N; Omar S; Heijnen M; Schallig H; Kager PA
Trop Med Int Health; 2007 Feb; 12(2):238-44. PubMed ID: 17300631
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
